BIOMAT Database Logo BIOMAT Database Logo

Western blot criteria for HTLV-I. 1991

T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki

UI MeSH Term Description Entries
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015683 Gene Products, gag Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. Viral gag Proteins,gag Antigen,gag Gene Product,gag Gene Products,gag Polyproteins,gag Protein,gag Viral Proteins,Gene Product, gag,Retroviral Antigen gag Protein,gag Antigens,gag Gene Related Protein,gag Polyprotein,Antigen, gag,Antigens, gag,Polyprotein, gag,Polyproteins, gag,Protein, gag,Proteins, Viral gag,Proteins, gag Viral,Viral Proteins, gag,gag Proteins, Viral
D015686 Gene Products, env Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. env Gene Products,env Polyproteins,env Protein,env Antigens,env Glycoproteins,env Polyprotein,Antigens, env,Polyprotein, env,Polyproteins, env

Related Publications

T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
AIDS: proposed WHO criteria for interpreting western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II.
January 1991, Bulletin of the World Health Organization,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
Distinguishing between HTLV-I and HTLV-II by western blot.
June 1990, Lancet (London, England),
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
Re-evaluation of anti-HTLV-I Western blot assay using HTLV-I and HTLV-II serum panels.
August 1995, Clinical and diagnostic virology,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
Modified western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II.
July 1994, The new microbiologica,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II.
September 1990, Releve epidemiologique hebdomadaire,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
HTLV-I infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques.
January 1992, Leukemia,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
August 2011, Viruses,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
False-positive Western blot tests for antibodies to HTLV-III.
July 1986, JAMA,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.
September 1999, The Journal of infectious diseases,
T Kiyokawa, and K Yamaguchi, and Y Nishimura, and N Fukuoka, and T Watanabe, and K Takatsuki
HTLV-I "indeterminate" western blot patterns observed in sera from tropical regions: the situation revisited.
July 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Copied contents to your clipboard!